"Our basic drugs in the service of humanity worldwide"
Company
About Company
Mission & Vision
Quality Policy
Leadership
Plant & Facilities
Products
APIs
Drug Intermediates
Fine Chemicals
R&D
Contract Manufacturing
Investors
Shareholder Information
Corporate Governance
Financial Information
General Meetings
Regulation 46
Careers
Company
About Company
Mission & Vision
Quality Policy
Leadership
Plant & Facilities
Products
APIs
Drug Intermediates
Fine Chemicals
R&D
Contract Manufacturing
Investors
Shareholder Information
Corporate Governance
Financial Information
General Meetings
Regulation 46
Careers
Contact Us
Board Meeting Outcome
Home
»
Board Meeting Outcome
Shareholder Information
Corporate Information
Shareholding pattern
RTA details
KYC Forms for Shareholders
Corporate Governance
Corporate Updates
Policies
Board & Committee Composition
Financial Information
Financial Results
Board Meeting Intimation
Board Meeting Outcome
General Meetings
Annual Report
Annual Return
Voting Results
AGM/EGM proceedings
AGM/EGM Notice
Regulation 46
Regulation 46
Select Year
2025-26
2024-25
2023-24
2022-23
2021-22
2020-21
2019-20
2025-26
Outcome 13.06.2025
Outcome 30.06.2025
Outcome 30.09.2025
Outcome 31.12.2025
2024-25
Outcome 30.06.2024
Outcome 30.09.2024
Outcome 31.12.2024
Outcome 31.03.2025
2023-24
Outcome 30.06.2023
Outcome 30.09.2023
Outcome 31.12.2023
Outcome 31.03.2024
2022-23
Outcome 30.06.2022
Outcome 30.09.2022
Outcome 31.12.2022
Outcome 31.03.2023
2021-22
Outcome 30.06.2021
Outcome 30.09.2021
Outcome 31.12.2021
Outcome 31.03.2022
2020-21
Outcome 30.06.2020
Outcome 30.09.2020
Outcome 31.12.2020
Outcome 31.03.2021
2019-20
Outcome 30.06.2019
Outcome 30.09.2019
Outcome 31.12.2019
Outcome 31.03.2020
